Enhanced Expression of WD Repeat-Containing Protein 35 via CaMKK/AMPK Activation in Bupivacaine-Treated Neuro2a Cells
- Type
- Expression of concern
- Notice date
- 2/22/2019 0:00
- Journal
- PLoS One
- Publisher
- PLoS
- Notice DOI
- 10.1371/journal.pone.0213041
- Original paper DOI
- 10.1371/journal.pone.0098185